Table 1.
Study | Type of Study | Number of patients | Number of exposed | Number of non-exposed | Total Afib | AF in non-exposed | AF in exposed | P value/CI |
---|---|---|---|---|---|---|---|---|
Mehra et al. [7] | Cross-sectional | 566 | 228 | 338 | 14 | 3 | 11 | 1.03–15.74 |
Tanigawa et al. [8] | Prevalence | 1663 | 688 | 975 | 26 | 7 | 19 | P<0.001 |
Gami et al. [9] | Retrospective cohort | 3542 | 2626 | 916 | 133 | 19 | 114 | 1.34 to 3.54 |
Zhao et al. [10] | prospective | 160 | 128 | 32 | 36 | 4 | 32 | p=0.07 |
Wong et al. [11] | Retrospective | 545 | 72 | 473 | 226 | 178 | 48 | 1.3–2.58 |
Cadby et al. [12] | Prospective | 6841 | 4352 | 2489 | 455 | 81 | 374 | 2.06–3.34 |
Mehra et al. [13] | cross-sectional | 2911 | 2184 | 727 | 138 | 23 | 115 | P<0.001 |
Selim et al. [14] | Cross-sectional | 697 | 537 | 160 | 38 | 4 | 34 | P>0.05 |
Tung et al. [15] | Prospective | 2912 | 1440 | 1472 | 338 | 142 | 196 | P>0.05 |